Variant report
Variant | nsv976227 |
---|---|
Chromosome Location | chr13:66731801-66738354 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530173859 | chr13:66733422-66733423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546687482 | chr13:66733458-66733459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139269411 | chr13:66733483-66733484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117844680 | chr13:66733486-66733487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552822979 | chr13:66733487-66733488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141891200 | chr13:66733560-66733561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558086659 | chr13:66733615-66733616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113058762 | chr13:66733710-66733711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114760259 | chr13:66733723-66733724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145420757 | chr13:66733748-66733749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192989670 | chr13:66733751-66733752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74494939 | chr13:66733776-66733777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561994287 | chr13:66733793-66733794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572794191 | chr13:66733794-66733795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576377075 | chr13:66733806-66733807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549116857 | chr13:66733845-66733846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184344778 | chr13:66733860-66733861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575579870 | chr13:66733934-66733935 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1407582 | chr13:66733963-66733964 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs527960307 | chr13:66734004-66734005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372263539 | chr13:66734214-66734215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547807133 | chr13:66734272-66734273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573953702 | chr13:66734286-66734287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147697840 | chr13:66734302-66734303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541215719 | chr13:66734305-66734306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140879576 | chr13:66734380-66734381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532521172 | chr13:66734388-66734389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149513020 | chr13:66734393-66734394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs34458909 | chr13:66734394-66734395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546730620 | chr13:66734404-66734405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552478712 | chr13:66734406-66734407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377109224 | chr13:66734427-66734428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569232518 | chr13:66734444-66734445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61315261 | chr13:66734454-66734455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368461858 | chr13:66734471-66734472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548384568 | chr13:66734479-66734480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78465787 | chr13:66734510-66734511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187887017 | chr13:66734513-66734514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9599077 | chr13:66734535-66734536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376808018 | chr13:66734671-66734672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545152852 | chr13:66734679-66734680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553026465 | chr13:66734684-66734685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10507730 | chr13:66734699-66734700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs193025737 | chr13:66734744-66734745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145839862 | chr13:66734761-66734762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111847709 | chr13:66734821-66734822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544468902 | chr13:66734825-66734826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35317639 | chr13:66734846-66734847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539832739 | chr13:66734872-66734873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533454150 | chr13:66734940-66734941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66733400-66733800 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr13:66733600-66734000 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr13:66733800-66737400 | Weak transcription | Placenta Amnion | Placenta Amnion |
4 | chr13:66736400-66737600 | Enhancers | Dnd41 | blood |
5 | chr13:66736600-66737200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr13:66737200-66737600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr13:66737400-66737600 | Enhancers | Placenta Amnion | Placenta Amnion |
8 | chr13:66737600-66737800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr13:66737800-66738800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |